Pharmadrug Inc C.PHRX

Alternate Symbol(s): LMLLF

Medical Care Cannabis

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.

CSE:PHRX - Post by User

Pharmadrug Inc > terry booth

<< Previous

Bullboard Posts

Next >>

Comment by SamRothsteinon Feb 11, 2021 3:12pm

119 Views

Post# 32543305

RE:RE:terry booth

Bruce Linton hasn't bought shares of TRIP yet either, maybe that is why you also think that TRIP is going to zero. Linton and Booth both have shares/options already, even if they aren't buying more right now. There are also blackout periods on when they can buy shares (if they chose to) based on developments being released. But you know all this. As usual, you just want to make something appear sinister so that you can desperately try in vain to pull your disastrous short out of the fire. Just close your doomed short and hit the bricks pennywise.